| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Medical preparations | |
| #5 | Acyclic or carbocyclic compounds | |
| #6 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Roberts Edward | 13 |
| #2 | Ahmad Sultan | 10 |
| #3 | Shen Shi-Hsiang | 9 |
| #4 | Banville Denis | 8 |
| #5 | Delorme Daniel | 8 |
| #6 | Lembo Paola | 8 |
| #7 | Fortin Yves | 8 |
| #8 | O'Donell Dajan | 7 |
| #9 | Sun Eric | 4 |
| #10 | Plobeck Niklas | 4 |
| Publication | Filing date | Title |
|---|---|---|
| US6974825B1 | Compounds with analgesic effect | |
| US6387949B1 | Substituted urea compounds useful in pain management | |
| US6800749B1 | G-protein coupled receptor | |
| CZ20002315A3 | Novel receptor coupled with G-protein | |
| BR9814335A | Protein, except those existing in the natural, substantially pure polynucleotide, antibody elaborated by a process comprising the step of injecting a pharmaceutically acceptable preparation, vector to express rat drr-1, vector, rat drr-1 host cell, drr- Human 1, human drr-2, human drr-3, human drr-4, human drr-5, recombinant human drr-6, and, process for testing a test compound as to its ability to bind to or activate a specific dorsal root ganglia receptor linked to the g (drr) protein |